查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827696

2025年3D生物列印全球市場報告

3D Bioprinting Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，3D生物列印市場快速擴張，市場規模從2024年的18.6億美元成長到2025年的21.9億美元，複合年成長率達18.2%。預測期內的成長歸因於研發資金的增加、慢性病的增加、器官短缺、藥物檢測的增加以及組織工程的發展。

預計未來幾年，3D生物列印市場規模將呈指數級成長，到2029年將達到50.4億美元，複合年成長率為23.1%。預測期內的成長可歸因於醫療保健的進步、生物列印皮膚的蓬勃發展、患者意識的提升以及人口老化。預測期內的主要趨勢包括多材料列印、血管生成技術、器官晶片、客製化植入以及太空生物製造。

3D生物列印是一種積層製造技術，它可以逐層列印出模擬生物系統行為的活體結構。該技術利用細胞和生物相容性材料，通常稱為生物墨水。 3D生物列印材料的主要應用領域是藥物研究，以及近期用於建造細胞骨架以修復受損的韌帶和關節。

3D生物列印的關鍵組件是3D生物列印機和生物墨水。 3D生物列印機採用3D技術，利用生物相容性材料複製各種身體部位，進而實現組織、骨骼、器官、血管和生物醫學組件的生物列印。此過程涉及的材料包括活細胞、水凝膠和細胞外基質。 3D生物列印在研究和臨床領域有著廣泛的應用，並正在研究機構、學術機構、生物製藥公司和醫院等多個領域開展應用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制價格上漲，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、加強標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供 3D 生物列印市場統計數據，例如 3D 生物列印行業的全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的 3D 生物列印行業細分市場、市場趨勢和商機，以及您在 3D 生物列印行業取得成功所需的數據。本 3D 生物列印市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長23.1%，較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這將對美國產生直接影響，限制其獲取瑞士生物墨水配方和德國精密擠出噴嘴，從而減緩其在組織工程應用方面的研究。此外，由於互惠關稅以及貿易緊張局勢和限制措施不斷升級對全球經濟和貿易的負面影響，這一影響也將更加廣泛地顯現出來。

預計在預測期內，支持 3D 生物列印研究活動的政府和私人資金不斷增加將推動 3D 生物列印市場的成長。 3D 生物列印在醫療保健領域的應用日益廣泛，吸引了政府和私人組織的資金。這筆資金包括對 3D 生物列印技術各個開發階段的財務和技術支援。例如，2022 年 5 月，瑞士生物列印公司 Readily3d SA 從歐盟獲得 60 萬美元的資助，用於利用該公司的 Tomolite 3D 生物列印技術開發胰腺活體微型模型。澳洲衛生部長向科廷大學撥款 737,690 美元，用於開發和最佳化一種 3D 技術，將皮膚組織直接生物列印到模型傷口中，作為人體皮膚修復的先決條件。

慢性病的預期成長將推動3D生物列印市場的未來成長。由於慢性病通常持續超過三個月，並且往往是終生的，因此3D生物列印擴大被用於創建組織模型，以協助慢性病研究和潛在的器官替代療法。例如，根據世界衛生組織（WHO）在2022年9月發布的報告，全球整體每年約有4,100萬人死亡，佔所有死亡人數的74%。這個驚人的數字包括1,790萬人死於心血管疾病，930萬人死於癌症，410萬人死於慢性呼吸道疾病，200萬人死於糖尿病。因此，慢性病的快速增加是3D生物列印市場成長的主要驅動力。

3D生物列印市場的主要企業正專注於開發用於組織工程和再生醫學的下一代生物列印機。生物3D列印機是一種專用設備，它使用由活細胞和生物相容性材料製成的生物墨水來建造組織和器官等生物結構。例如，2022年11月，印度醫療保健公司Abbey Biosciences推出了MitoPlus。這款印表機有助於創建複雜的人體組織，解決了器官短缺和改善藥物檢測方法等關鍵問題。其主要特點包括精確的溫度控制（4°C至80°C）、相容於多種生物材料的雙擠出機系統、內置紫外線固化功能（可提高組織品質）以及高效能空氣微粒子過濾器（HEPA），可保持列印環境的無菌。

3D 生物列印市場的主要企業正專注於開發創新技術解決方案，例如 3D 生物列印機，以提高組織工程和再生醫學的精確度和效率。 3D 生物列印機利用含有活細胞的生物墨水來創建3D組織和器官結構，用於醫學研究和再生醫學應用。例如，2024 年 6 月，美國陶瓷粉末和金屬聚合物產品開發商 Tethon 3D 推出 Bison Bio DLP 3D 生物列印機，進入生物列印市場。這款先進的印表機是與 Carima 合作開發的，提供可調的建造尺寸（30 x 20 毫米、57 x 32 毫米和 96 x 54 毫米），並與 Tethon 專有的 LAP 光光引發劑和 GelMA 水凝膠生物墨水相容，這對於生物列印活組織至關重要。 Bison Bio 的尺寸為 24 x 24 x 24 英寸，重 75 磅，售價為 19,950 美元，旨在透過創建用於生物醫學研究的複雜組織和器官、支持個性化醫療和再生療法來加速醫療保健的進步。

2022年5月，專注於3D生物列印技術的瑞典生技公司BICO宣布以600萬美元收購Allegro 3D。此次收購旨在透過整合先進技術並擴大市場覆蓋範圍，支持BICO的策略目標。 Allegro 3D位於聖地牙哥，專注於基於光的列印技術，將增強BICO的現有實力。

3D 生物列印市場的主要企業包括 Organovo Holdings Inc.、Allevi Inc.、Cellink AB、Aspect Biosystems Ltd.、3D Systems Corporation、Cyfuse Biomedical KK、EnvisionTEC GmbH、Poietis SA、TeVido BioDevices、Nano3D Biosciences Inc.、Dirlab Inc.、Recidanced、Ftak 或t. BIoTechnology Co.Ltd.、Regemat 3D SL、Bio3D Technologies、Stratasys Ltd.、ROKIT Healthcare Co.Ltd.、Inventia Life Science Pvt。 Ltd.、Vivax Bio LLC、GE HealthCare Technologies Inc.、3D BIoTek LLC、Nuclera Nucleics Ltd.、3D Fortify Inc.、Carbon Inc.、Divergent Technologies Inc.、Markforged Inc.、SprintRay Inc.、3D Bio Corp、3D Bioprinting Solutions、BICO Group AB、Collat​​​​y Ltd.和 Modern Meadow Inc.

2024年，3D生物列印市場最大的地區將是北美。預計在預測期內，亞太地區將成為3D生物列印市場成長最快的地區。 3D生物列印市場報告涵蓋以下地區：亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

3D生物列印市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

3D生物列印市場包括擠出式生物列印、噴墨式生物列印、雷射輔助生物列印和立體光刻技術生物列印的銷售。該市場的價值是指“出廠價”，即商品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球 3D 生物列印：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球3D生物列印市場：成長率分析
  • 全球3D生物列印市場表現：規模與成長，2019-2024年
  • 全球3D生物列印市場預測：規模與成長，2024-2029年，2034年
  • 全球 3D 生物列印：總目標市場 (TAM)

第6章 市場細分

  • 全球 3D 生物列印市場（按組件、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 3D生物列印機
  • 生物墨水
  • 全球 3D 生物列印市場（按材料、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 活細胞
  • 水凝膠
  • 細胞外基質
  • 其他
  • 全球3D生物列印市場的應用、效能與預測（2019-2024年、2024-2029年、2034年）
  • 研究用途
  • 臨床應用
  • 其他
  • 全球 3D 生物列印市場（依最終用戶分類）：2019-2024 年、2024-2029 年、2034 年業績及預測
  • 研究和學術機構
  • 生物製藥公司
  • 醫院
  • 其他
  • 全球 3D 生物列印市場：3D 生物列印機細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 噴墨3D生物列印機
  • 微擠壓3D生物列印機
  • 雷射輔助3D生物列印機
  • 立體光刻技術（SLA）生物印表機
  • 全球 3D 生物列印市場：生物墨水細分市場、類型、效能及預測（2019-2024 年、2024-2029 年、2034 年）
  • 天然生物墨水
  • 合成生物墨水
  • 混合生物墨水
  • 水凝膠

第7章 區域和國家分析

  • 全球3D生物列印市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球 3D 生物列印市場：國家、績效與預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 3D生物列印市場：競爭格局
  • 3D生物列印市場：公司簡介
    • Organovo Holdings Inc.
    • Allevi Inc.
    • Cellink AB
    • Aspect Biosystems Ltd.
    • 3D Systems Corporation

第31章：其他領先和創新企業

  • Cyfuse Biomedical KK
  • EnvisionTEC GmbH
  • Poietis SA
  • TeVido BioDevices
  • Nano3D Biosciences Inc.
  • Digilab Inc.
  • RegenHU Ltd.
  • GeSiM mbH
  • Advanced Solutions Life Sciences LLC
  • Regenovo BIoTechnology Co. Ltd.
  • Regemat 3D SL
  • Bio3D Technologies
  • Stratasys Ltd.
  • ROKIT Healthcare Co. Ltd.
  • Inventia Life Science Pvt. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年3D生物列印市場：提供新機會的國家
  • 2029年3D生物列印市場：細分領域帶來新機會
  • 2029年3D生物列印市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r20918u

3D Bioprinting, a form of additive manufacturing, involves the layer-by-layer printing of live structures that emulate the behavior of living systems. This process utilizes cells and biocompatible materials, commonly referred to as bio-inks. The primary application of 3D bioprinting materials is in drug research, and more recently, in the creation of cell scaffolds for repairing damaged ligaments and joints.

The key components in 3D bioprinting include 3D bioprinters and bio-inks. 3D bioprinters employ three-dimensional technology along with biocompatible materials to replicate various body parts, facilitating the bioprinting of tissues, bones, organs, blood vessels, and biomedical components. The materials involved in the process encompass living cells, hydrogels, extracellular matrices, and others. The application of 3D bioprinting extends to research and clinical settings, among others, and finds implementation in diverse sectors such as research organizations, academic institutes, biopharmaceutical companies, hospitals, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The 3D bioprinting market research report is one of a series of new reports from The Business Research Company that provides 3D bioprinting market statistics, including 3D bioprinting industry global market size, regional shares, competitors with a 3D bioprinting market share, detailed 3D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 3D bioprinting industry. This 3D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D bioprinting market size has grown rapidly in recent years. It will grow from $1.86 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to research and development funding, growth in chronic diseases, organ shortage, rise in pharmaceutical testing, growth in tissue engineering.

The 3D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $5.04 billion in 2029 at a compound annual growth rate (CAGR) of 23.1%. The growth in the forecast period can be attributed to healthcare advancements, rising development of bioprinted skin, growing awareness among patients, aging population. Major trends in the forecast period include multi-material printing, vascularization techniques, organ-on-a-chip, custom implants, biofabrication in space.

The forecast of 23.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through restricted access to bioink formulations from Switzerland and precision extrusion nozzles from Germany, slowing research in tissue engineering applications.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting is increasing applications in healthcare attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques. For instance, in May 2022, Readily3d SA, a Switzerland-based bioprinting company, received funding of $600,000 from the European Union to develop a living miniature model of the pancreas using its Tomolite 3D bioprinting technique. The Australian Minister for Health funded Curtin University with $737,690 to develop and optimize 3D technology for bioprinting skin tissue directly onto model wounds as a prelude to human skin restoration

The anticipated rise in chronic diseases is set to be a driving factor in the prospective growth of the 3D bioprinting market. Chronic diseases, persisting over extended periods-typically three months or more, and often for a person's lifetime-have increasingly utilized 3D bioprinting for creating tissue models, aiding in chronic disease research and potential organ replacement therapies. For example, as per the World Health Organization's September 2022 report, approximately 41 million deaths globally annually, representing 74% of fatalities, are attributed to non-communicable diseases (NCDs) or chronic diseases. This alarming figure includes 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the upsurge in chronic diseases is a significant driver behind the growth of the 3D bioprinting market.

Leading companies in the 3D bioprinting market are focusing on developing next-generation bioprinters for use in tissue engineering and regenerative medicine. A bio 3D printer is a specialized device that constructs biological structures, such as tissues and organs, using bioinks made from living cells or biocompatible materials. For example, in November 2022, Avay Biosciences, an India-based healthcare company, launched the Mito Plus. This printer facilitates the creation of complex human tissues, addressing critical challenges like organ shortages and improving drug testing methodologies. Key features include precise temperature control (ranging from 4°C to 80°C), a dual-extruder system for multiple biomaterials, inbuilt UV curing to enhance tissue quality, and HEPA filters to maintain a sterile printing environment

Major companies in the 3D bioprinting market are focusing on developing innovative technological solutions, such as 3D bioprinters, to improve precision and efficiency in tissue engineering and regenerative medicine. 3D bioprinters are devices that utilize bioinks containing living cells to produce three-dimensional tissue and organ structures for medical research and regenerative medicine applications. For example, in June 2024, Tethon 3D, a US-based developer of ceramic powder and metal-polymer products, introduced the Bison Bio DLP 3D bioprinter, marking its entry into the bioprinting market. Developed in collaboration with Carima, this advanced printer offers adjustable build sizes (30 X 20 mm, 57 X 32 mm, and 96 X 54 mm) and is compatible with Tethon's proprietary LAP photoinitiator and GelMA hydrogel bioink, crucial for bioprinting living tissues. Measuring 24 X 24 X 24 inches and weighing 75 lbs, the Bison Bio is priced at $19,950 and aims to drive advancements in healthcare by enabling the creation of complex tissues and organs for biomedical research, supporting personalized medicine and regenerative therapies

In May 2022, BICO, a biotechnology company from Sweden focused on 3D bioprinting technology, announced the acquisition of Allegro 3D, Inc. for $6 million. This acquisition is intended to support BICO's strategic objectives by incorporating advanced technology and broadening its market reach. Allegro 3D, Inc., located in San Diego, specializes in light-based printing technology, which enhances BICO's current capabilities.

Major companies operating in the 3D bioprinting market include Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.

North America was the largest region in the 3D bioprinting market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period. The regions covered in the 3D bioprinting market report analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the 3D bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The 3D bioprinting market consists of sales of extrusion-based bioprinting, inkjet-based bioprinting, laser-assisted bioprinting, and stereolithography bioprinting. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Bioprinting Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d bioprinting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d bioprinting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: 3D Bioprinters; Bioinks
  • 2) By Material: Living Cells; Hydrogels; Extracellular Matrices; Other Materials
  • 3) By Application: Research Applications; Clinical Application; Other Applications
  • 4) By End User: Research Organization And Academic Institutes; Biopharmaceuticals Companies; Hospitals; Other End Users
  • Subsegments:
  • 1) By 3D Bioprinters: Inkjet 3D Bioprinters; Microextrusion 3D Bioprinters; Laser-Assisted 3D Bioprinters; Stereolithography (SLA) Bioprinters
  • 2) By Bioinks: Natural Bioinks; Synthetic Bioinks; Hybrid Bioinks; Hydrogels
  • Companies Mentioned: Organovo Holdings Inc.; Allevi Inc.; Cellink AB; Aspect Biosystems Ltd.; 3D Systems Corporation; Cyfuse Biomedical KK; EnvisionTEC GmbH; Poietis SA; TeVido BioDevices; Nano3D Biosciences Inc.; Digilab Inc.; RegenHU Ltd.; GeSiM mbH; Advanced Solutions Life Sciences LLC; Regenovo Biotechnology Co. Ltd.; Regemat 3D S.L.; Bio3D Technologies; Stratasys Ltd.; ROKIT Healthcare Co. Ltd.; Inventia Life Science Pvt. Ltd.; Vivax Bio LLC; GE HealthCare Technologies Inc.; 3D Biotek LLC; Nuclera Nucleics Ltd.; 3D Fortify Inc.; Carbon Inc.; Divergent Technologies Inc.; Markforged Inc.; SprintRay Inc.; 3D Bio Corp; 3D Bioprinting Solutions; BICO Group AB; CollPlant Biotechnologies Ltd.; Shining 3D Tech Co. Ltd.; 3Dynamic Systems Ltd.; Modern Meadow Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Bioprinting Market Characteristics

3. 3D Bioprinting Market Trends And Strategies

4. 3D Bioprinting Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global 3D Bioprinting Growth Analysis And Strategic Analysis Framework

  • 5.1. Global 3D Bioprinting PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global 3D Bioprinting Market Growth Rate Analysis
  • 5.4. Global 3D Bioprinting Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global 3D Bioprinting Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global 3D Bioprinting Total Addressable Market (TAM)

6. 3D Bioprinting Market Segmentation

  • 6.1. Global 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 3D Bioprinters
  • Bioinks
  • 6.2. Global 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Materials
  • 6.3. Global 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Applications
  • Clinical Application
  • Other Applications
  • 6.4. Global 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Organization And Academic Institutes
  • Biopharmaceuticals Companies
  • Hospitals
  • Other End Users
  • 6.5. Global 3D Bioprinting Market, Sub-Segmentation Of 3D Bioprinters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inkjet 3D Bioprinters
  • Microextrusion 3D Bioprinters
  • Laser-Assisted 3D Bioprinters
  • Stereolithography (SLA) Bioprinters
  • 6.6. Global 3D Bioprinting Market, Sub-Segmentation Of Bioinks, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Bioinks
  • Synthetic Bioinks
  • Hybrid Bioinks
  • Hydrogels

7. 3D Bioprinting Market Regional And Country Analysis

  • 7.1. Global 3D Bioprinting Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global 3D Bioprinting Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific 3D Bioprinting Market

  • 8.1. Asia-Pacific 3D Bioprinting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China 3D Bioprinting Market

  • 9.1. China 3D Bioprinting Market Overview
  • 9.2. China 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India 3D Bioprinting Market

  • 10.1. India 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan 3D Bioprinting Market

  • 11.1. Japan 3D Bioprinting Market Overview
  • 11.2. Japan 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia 3D Bioprinting Market

  • 12.1. Australia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia 3D Bioprinting Market

  • 13.1. Indonesia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea 3D Bioprinting Market

  • 14.1. South Korea 3D Bioprinting Market Overview
  • 14.2. South Korea 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe 3D Bioprinting Market

  • 15.1. Western Europe 3D Bioprinting Market Overview
  • 15.2. Western Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK 3D Bioprinting Market

  • 16.1. UK 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany 3D Bioprinting Market

  • 17.1. Germany 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France 3D Bioprinting Market

  • 18.1. France 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy 3D Bioprinting Market

  • 19.1. Italy 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain 3D Bioprinting Market

  • 20.1. Spain 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe 3D Bioprinting Market

  • 21.1. Eastern Europe 3D Bioprinting Market Overview
  • 21.2. Eastern Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia 3D Bioprinting Market

  • 22.1. Russia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America 3D Bioprinting Market

  • 23.1. North America 3D Bioprinting Market Overview
  • 23.2. North America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA 3D Bioprinting Market

  • 24.1. USA 3D Bioprinting Market Overview
  • 24.2. USA 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada 3D Bioprinting Market

  • 25.1. Canada 3D Bioprinting Market Overview
  • 25.2. Canada 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America 3D Bioprinting Market

  • 26.1. South America 3D Bioprinting Market Overview
  • 26.2. South America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil 3D Bioprinting Market

  • 27.1. Brazil 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East 3D Bioprinting Market

  • 28.1. Middle East 3D Bioprinting Market Overview
  • 28.2. Middle East 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa 3D Bioprinting Market

  • 29.1. Africa 3D Bioprinting Market Overview
  • 29.2. Africa 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. 3D Bioprinting Market Competitive Landscape And Company Profiles

  • 30.1. 3D Bioprinting Market Competitive Landscape
  • 30.2. 3D Bioprinting Market Company Profiles
    • 30.2.1. Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Allevi Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Cellink AB Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. 3D Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

31. 3D Bioprinting Market Other Major And Innovative Companies

  • 31.1. Cyfuse Biomedical KK
  • 31.2. EnvisionTEC GmbH
  • 31.3. Poietis SA
  • 31.4. TeVido BioDevices
  • 31.5. Nano3D Biosciences Inc.
  • 31.6. Digilab Inc.
  • 31.7. RegenHU Ltd.
  • 31.8. GeSiM mbH
  • 31.9. Advanced Solutions Life Sciences LLC
  • 31.10. Regenovo Biotechnology Co. Ltd.
  • 31.11. Regemat 3D S.L.
  • 31.12. Bio3D Technologies
  • 31.13. Stratasys Ltd.
  • 31.14. ROKIT Healthcare Co. Ltd.
  • 31.15. Inventia Life Science Pvt. Ltd.

32. Global 3D Bioprinting Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Bioprinting Market

34. Recent Developments In The 3D Bioprinting Market

35. 3D Bioprinting Market High Potential Countries, Segments and Strategies

  • 35.1 3D Bioprinting Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 3D Bioprinting Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 3D Bioprinting Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer